Google has announced a new partnership with Masimo to enhance health tracking features on Wear OS devices. The collaboration, which also involves Qualcomm, aims to address the health data challenges users have faced with Wear OS. Masimo’s advanced blood oxygen technology and other proprietary health features will be integrated into Wear OS to provide more accurate and reliable health tracking.
The company’s platform is known for its precision in measuring vital signs, and its integration with Wear OS is expected to ensure smooth syncing with Android devices. While manufacturers of Wear OS smartwatches can still design their device exteriors and user interfaces, the internal health tracking technology will be standardized through this partnership. Masimo will handle the design, production, and testing of embedded sensors and health monitoring tech.
Masimo integrates health tech with Wear OS
Masimo, recognized for its innovative medical technology, previously made headlines for its legal battle with Apple over blood oxygen tracking tech in the Apple Watch. The partnership with Google signifies a new strategic direction for Masimo, focusing on enhancing health tracking in Wear OS devices.
The collaboration aims to provide a reference framework to help manufacturers expedite the development of smartwatches with advanced health features. This aligns with Google’s vision to elevate the capabilities of its wearable platform, offering consumers a variety of health tracking options across different price points. The new reference platform is seamlessly integrated into the Wear OS ecosystem, aiming for accurate health data collection and effortless syncing with Android smartphones.
This initiative allows smartwatch makers to focus on aesthetic and user interface design while relying on Masimo for critical health tech components. The partnership is a notable step in Google’s efforts to bolster the functionality and appeal of Wear OS devices, promising enhanced health tracking features for users.